Procyon Advisors LLC Boosts Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Procyon Advisors LLC grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 3.6% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 21,550 shares of the healthcare conglomerate’s stock after buying an additional 749 shares during the period. UnitedHealth Group accounts for approximately 1.0% of Procyon Advisors LLC’s portfolio, making the stock its 21st largest position. Procyon Advisors LLC’s holdings in UnitedHealth Group were worth $11,346,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the company. Kraft Davis & Associates LLC lifted its position in shares of UnitedHealth Group by 3.4% in the third quarter. Kraft Davis & Associates LLC now owns 577 shares of the healthcare conglomerate’s stock valued at $294,000 after acquiring an additional 19 shares in the last quarter. Iron Horse Wealth Management LLC boosted its holdings in UnitedHealth Group by 1.6% in the 3rd quarter. Iron Horse Wealth Management LLC now owns 1,217 shares of the healthcare conglomerate’s stock worth $614,000 after acquiring an additional 19 shares during the period. Secure Asset Management LLC raised its position in shares of UnitedHealth Group by 0.8% in the 3rd quarter. Secure Asset Management LLC now owns 2,456 shares of the healthcare conglomerate’s stock valued at $1,238,000 after purchasing an additional 19 shares in the last quarter. Bensler LLC lifted its holdings in UnitedHealth Group by 0.3% during the 3rd quarter. Bensler LLC now owns 7,293 shares of the healthcare conglomerate’s stock worth $3,677,000 after buying an additional 19 shares during the last quarter. Finally, Texas Capital Bancshares Inc TX boosted its holdings in UnitedHealth Group by 1.1% in the third quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate’s stock worth $855,000 after purchasing an additional 19 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

UNH has been the topic of a number of recent research reports. Stephens reiterated an “overweight” rating and issued a $605.00 target price on shares of UnitedHealth Group in a research note on Thursday, February 8th. HSBC restated a “reduce” rating and issued a $480.00 price target (down previously from $550.00) on shares of UnitedHealth Group in a research note on Monday, December 18th. Piper Sandler reduced their price objective on shares of UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating for the company in a report on Wednesday, January 17th. Royal Bank of Canada reissued an “outperform” rating and issued a $596.00 price target on shares of UnitedHealth Group in a report on Thursday, February 29th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a report on Friday, January 19th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $579.33.

Insider Buying and Selling

In other news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In related news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. Corporate insiders own 0.35% of the company’s stock.

UnitedHealth Group Stock Performance

UnitedHealth Group stock traded down $2.18 on Thursday, hitting $490.92. The company’s stock had a trading volume of 385,367 shares, compared to its average volume of 4,038,452. UnitedHealth Group Incorporated has a one year low of $445.68 and a one year high of $554.70. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.62. The firm has a market cap of $452.59 billion, a P/E ratio of 20.68, a price-to-earnings-growth ratio of 1.34 and a beta of 0.54. The company has a fifty day moving average price of $503.73 and a 200-day moving average price of $518.79.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 EPS for the quarter, beating the consensus estimate of $5.98 by $0.18. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The business had revenue of $94.43 billion for the quarter, compared to analyst estimates of $92.13 billion. During the same quarter in the previous year, the firm earned $5.34 EPS. UnitedHealth Group’s quarterly revenue was up 14.1% on a year-over-year basis. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 27.82 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a $1.88 dividend. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.53%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 31.54%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.